“We believe this case is potentially groundbreaking," one interventional cardiologist said. 

Michael J. Barry, MD, vice chair of the U.S. Preventive Services Task Force, gave Cardiovascular Business an overview of the new recommendations.

The genetically modified pig heart appears to have been infected with a porcine virus, according to the surgeon who performed the initial transplant. 

Transcaval TAVR was linked to a much lower stroke rate and fewer bleeding complications. 

The new Shockwave Medical M5+ peripheral intravascular lithotripsy (IVL) catheter made its debut at ACC.22. 

A team of researchers used computer science and mathematics to study the "triple whammy" of diuretics, RAS inhibitors and NSAIDs.

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.

All formulations and concentrations of GE Healthcare’s Omnipaque (iohexol) are expected to be in short supply until mid-June due to COVID lockdowns where the contrast is manufactured.